Tazobactam and piperacillin-induced thrombocytopenia: A case report

Chen,Hong; Fan,Zhen; Guo,Fei; Yang,Yumin; Li,Jie; Zhang,Jie; Wang,Yudan; Le,Jianwei; Wang,Zhiyu; Zhu,Jianhua

doi:10.3892/etm.2016.3062

Tazobactam and piperacillin-induced thrombocytopenia: A case report

Authors:
- Hong Chen
- Zhen Fan
- Fei Guo
- Yumin Yang
- Jie Li
- Jie Zhang
- Yudan Wang
- Jianwei Le
- Zhiyu Wang
- Jianhua Zhu
View Affiliations

Affiliations: Intensive Care Unit, Ningbo First Hospital, Ningbo, Zhejiang 315000, P.R. China, Clinical Laboratory, Ningbo First Hospital, Ningbo, Zhejiang 315000, P.R. China
Published online on: February 9, 2016 https://doi.org/10.3892/etm.2016.3062
Pages: 1223-1226
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study reports a case of tazobactam and piperacillin (TZP)-induced thrombocytopenia in an elderly patient, from which complete clinical data and peripheral blood samples were collected. Platelet numbers were decreased 1 day following TZP treatment initiation; however, they were revealed to have increased 1‑2 days following withdrawal of TZP, and had reached normal levels 3‑5 days later. There was no evidence of bone marrow suppression, antibodies against peripheral plasma platelets were absent and levels of complement C3 were decreased. These results suggested that TZP was able to cause rapid and reversible thrombocytopenia, which was not associated with bone marrow suppression but may have involved activation of complement C3. The results of the present study therefore suggest that doctors should be aware of the risk of thrombocytopenia in patients treated with TZP.

View Figures

View References

1	Bautista AP, Buckler PW, Towler HM, Dawson AA and Bennett B: Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labeled platelets. Br J Haematol. 58:679–687. 1985. View Article : Google Scholar
2	Smock KJ and Perkins SL: Thrombocytopenia: An update. Int J Lab Hematol. 36:269–278. 2014. View Article : Google Scholar : PubMed/NCBI
3	Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al: International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 115:168–186. 2010. View Article : Google Scholar : PubMed/NCBI
4	Gonçalves-Pereira J and Póvoa P: Antibiotics in critically ill patients: A systematic review of the pharmacokinetics of β-lactams. Crit Care. 15:R2062011. View Article : Google Scholar : PubMed/NCBI
5	Bourget P, Lesne-Hulin A, Le Reveillé R, Le Bever H and Carsin H: Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection. Antimicrob Agents Chemother. 40:139–145. 1996.PubMed/NCBI
6	Finsterer J and Kotzailias N: Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets. 14:329–331. 2003. View Article : Google Scholar : PubMed/NCBI
7	Reichardt P, Handrick W, Linke A, Schille R and Kiess W: Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment - a retrospective analysis in 38 children with cystic fibrosis. Infection. 27:355–356. 1999. View Article : Google Scholar : PubMed/NCBI
8	Anand A and Chauhan HK: Piperacillin and vancomycin induced severe thrombocytopenia in a hospitalized patient. Platelets. 22:294–301. 2011. View Article : Google Scholar : PubMed/NCBI
9	Macwilliam JL, Mistry R, Floyd MS Jr and Baird AD: Piperacillin/tazobactam induced thrombocytopaenia - a delayed response. BMJ Case Rep. 2012:bcr03201259812012.PubMed/NCBI
10	Uzun G, Onem Y, Hatipoglu M, Turhan V, Mutluoglu M and Ay H: Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection. Scand J Infect Dis. 45:73–76. 2013. View Article : Google Scholar : PubMed/NCBI
11	Ramot Y and Nyska A: Drug-Induced Thrombosis - Experimental, clinical, and mechanistic considerations. Toxicol Pathol. 35:208–225. 2007. View Article : Google Scholar : PubMed/NCBI
12	Cines DB, Bussel JB, Liebman HA and Prak Luning ET: The ITP syndrome: Pathogenic and clinical diversity. Blood. 113:6511–6521. 2009. View Article : Google Scholar : PubMed/NCBI
13	Zhang L, Li H, Zhao H, Ji L and Yang R: Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: Experience from a single Chinese centre. Eur J Haematol. 70:196–197. 2003. View Article : Google Scholar : PubMed/NCBI
14	Macwilliam JL, Mistry R, Floyd MS Jr and Baird AD: Piperacillin/tazobactam-induced thrombocytopenia - a delayed response. BMJ Case Rep. 2012. View Article : Google Scholar : PubMed/NCBI
15	Shaik S, Kazi HA and Ender PT: Rapid-onset piperacillin-tazobactam induced thrombocytopenia. J Pharm Pract. 28:204–206. 2015. View Article : Google Scholar : PubMed/NCBI
16	Ruiz-Irastorza G, Barreiro G and Aguirre C: Reversible bone marrow depression by high-dose piperacillin/tazobactam. Br J Haematol. 95:611–612. 1996. View Article : Google Scholar : PubMed/NCBI
17	Kumar A, Choudhuri G and Aggarwal R: Piperacillin induced bone marrow suppression: A case report. BMC Clin Pharmacol. 3:22003. View Article : Google Scholar : PubMed/NCBI
18	Kelton JG, Meltzer D, Moore J, Giles AR, Wilson WE, Barr R, Hirsh J, Neame PB, Powers PJ, Walker I, et al: Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood. 58:524–529. 1981.PubMed/NCBI
19	Pérez-Vázquez A, Pastor JM and Riancho JA: Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis. 27:650–651. 1998. View Article : Google Scholar : PubMed/NCBI
20	Grégoire C, Brumpt C, Loirat D, Lau N, Bruel C, Philippart F, Couzigou C, Garrouste-Orgeas M and Misset B: A case of daptomycin-induced immune thrombocytopenia. Antimicrob Agents Chemother. 56:6430–6431. 2012. View Article : Google Scholar : PubMed/NCBI